This trial is active, not recruiting.

Condition magnetic resonance imaging, intestine small, crohn disease.
Treatment mri of the small bowel
Phase phase 3
Sponsor University of Oslo
Start date November 2004
End date June 2005
Trial size 40 participants
Trial identifier NCT00204165, 431-04150


The purpose of this study is to compare MRI enteroclysis with MRI of the small bowel with a per oral 6%mannitol solution.Our hypothesis is that the peroral technique preform the same way as MRI Enteroclysis.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Intervention model crossover assignment
Masking open label
Primary purpose diagnostic

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - above 18 years - known Crohns disease or strong suspicion. - need of a small bowel examination Exclusion Criteria: - pregnant - electrolyte disturbances. - Any MRI contraindications.

Additional Information

Official title MRI of the Small Bowel. Comparison of Different Techniques and Contrast.
Trial information was received from ClinicalTrials.gov and was last updated in September 2006.
Information provided to ClinicalTrials.gov by University of Oslo.